The effect of rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone scaffolds.

Our strategy entails investigating the influence of varied concentrations (0, 10, 100 and 1000ng/ml) of human recombinant bone morphogenetic protein-2 (rhBMP-2) on the osteogenic expression of canine osteoblasts, seeded onto poly-caprolactone 20% tricalcium phosphate (PCL-TCP) scaffolds in vitro. Biochemical assay revealed that groups with rhBMP-2 displayed an initial burst in cell growth that was not dose-dependent. However, after 13 days, cell growth declined to a value similar to control. Significantly less cell growth was observed for construct with 1000ng/ml of rhBMP-2 from 20 days onwards. Confocal microscopy confirmed viability of osteoblasts and at day 20, groups seeded with rhBMP-2 displayed heightened cell death as compared to control. Phase contrast and scanning electron microscopy revealed that osteoblasts heavily colonized surfaces, rods and pores of the PCL-TCP scaffolds. This was consistent for all groups. Finally, Von Kossa and osteocalcin assays demonstrated that cells from all groups maintained their osteogenic phenotype throughout the experiment. Calcification was observed as early as four days after stimulation for groups seeded with rhBMP-2. In conclusion, rhBMP-2 seems to enhance the differentiated function of canine osteoblasts in a non-dose dependent manner. This resulted in accelerated mineralization, followed by death of osteoblasts as they underwent terminal differentiation. Notably, PCL-TCP scaffolds seeded only with canine osteoblasts could sustain excellent osteogenic expression in vitro. Hence, the synergy of PCL with bioactive TCP and rhBMP-2 in a novel composite scaffold, could offer an exciting approach for bone regeneration.

[1]  C. V. van Blitterswijk,et al.  Use of an osteoinductive biomaterial as a bone morphogenetic protein carrier , 2001, Journal of materials science. Materials in medicine.

[2]  Hyun D Kim,et al.  Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. , 2002, Journal of biomedical materials research.

[3]  M. Nunn,et al.  Effect of recombinant human bone morphogenetic protein-2 on bone regeneration and osseointegration of dental implants. , 2001, Clinical oral implants research.

[4]  Y. Iwamoto,et al.  Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier: in vivo bone banking for muscle-pedicle autograft , 2002, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[5]  K. Shakesheff,et al.  Growth factor release from tissue engineering scaffolds , 2001, The Journal of pharmacy and pharmacology.

[6]  J. Jansen,et al.  Influence of rhBMP-2 on rat bone marrow stromal cells cultured on titanium fiber mesh. , 2001, Tissue engineering.

[7]  H. Uludaǧ,et al.  Carrier systems for bone morphogenetic proteins. , 1999, Clinical orthopaedics and related research.

[8]  D Breitig,et al.  Adsorption and release properties of growth factors from biodegradable implants. , 2002, Journal of biomedical materials research.

[9]  Dietmar W. Hutmacher,et al.  Preliminary study on the adhesion and proliferation of human osteoblasts on starch-based scaffolds , 2002 .

[10]  D. Hutmacher,et al.  Scaffolds in tissue engineering bone and cartilage. , 2000, Biomaterials.

[11]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[12]  S. Boden.  Bioactive factors for bone tissue engineering. , 1999, Clinical orthopaedics and related research.

[13]  K. Ishihara,et al.  Restoration of segmental bone defects in rabbit radius by biodegradable capsules containing recombinant human bone morphogenetic protein-2. , 2000, Journal of biomedical materials research.

[14]  I. Zein,et al.  Fused deposition modeling of novel scaffold architectures for tissue engineering applications. , 2002, Biomaterials.

[15]  A. Economides,et al.  0163-769X/03/$20.00/0 Endocrine Reviews 24(2):218–235 Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/er.2002-0023 Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton , 2022 .

[16]  I Zein,et al.  Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. , 2001, Journal of biomedical materials research.

[17]  T. Lim,et al.  Induction of Ectopic Bone Formation by Using Human Periosteal Cells in Combination with a Novel Scaffold Technology , 2002, Cell transplantation.

[18]  Shanaman Rh,et al.  Localized ridge augmentation using GBR and platelet-rich plasma: case reports. , 2001 .

[19]  J. Wozney,et al.  Engineering what comes naturally , 2003, Nature Biotechnology.

[20]  A. Reddi,et al.  Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. , 1997, Cytokine & growth factor reviews.

[21]  R. Shanaman,et al.  Localized ridge augmentation using GBR and platelet-rich plasma: case reports. , 2001, The International journal of periodontics & restorative dentistry.

[22]  T. Komori,et al.  Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. , 2000, Endocrine reviews.

[23]  Su-Gwan Kim,et al.  A comparative study of osseointegration of Avana implants in a demineralized freeze-dried bone alone or with platelet-rich plasma. , 2002, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[24]  C Krettek,et al.  Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, beta-tricalcium phosphate and demineralized bone matrix. , 2003, Biomaterials.

[25]  J. Wiltfang,et al.  Sinus floor augmentation with beta-tricalciumphosphate (beta-TCP): does platelet-rich plasma promote its osseous integration and degradation? , 2003, Clinical oral implants research.

[26]  K. Miyazono,et al.  Signal transduction by bone morphogenetic proteins. , 1998, Cytokine & growth factor reviews.

[27]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988 .

[28]  J. Schmitt,et al.  Bone morphogenetic proteins: An update on basic biology and clinical relevance , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[29]  D. Buchbinder,et al.  Maxillary sinus augmentation with deproteinated bovine bone and platelet rich plasma with simultaneous insertion of endosseous implants. , 2003, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.